Medical Hypnosis and Stress Reduction in Hospitalization

Stress Clinical Trial

— HYPNOSTRESS  

Official title:

Interest of Medical Hypnosis in Reducing Stress and Improving the Experience of Hospitalization in Internal Medicine

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05760014
• Other study ID #: 2022_0670
• Secondary ID: 2022-A02406-37
• Status: Not yet recruiting
• Start date: April 2023
• Est. completion date: December 2023

Study information

• Verified date: March 2023
• Source: University Hospital, Lille
• Contact: Meryem-Maud FARHAT, MD
• Phone: 0320445962
• Email: meryem.farhat[@]chru-lille.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Patients with chronic diseases, especially rare diseases with uncertain diagnoses, have a representation of their disease and an experience of their hospitalization that is sometimes traumatic, distressing and painful. Patients hospitalized can benefit from non-medicinal techniques, such as medical hypnosis, which could improve the perceived stress in these patients and thus optimize the hospitalization experience. The aim of this study is to evaluate the impact of medical hypnosis in reducing stress and improving the experience of hospitalization comparing two groups : a group (cases) benefiting from an hypnotic technic " the place of safety " and a control group without intervention during hospitalization

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: December 2023
• Est. primary completion date: November 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients hospitalised in the internal medicine department of the Lille University Hospital

• Age>= 18 years

• Patients having expressed their non opposition

Exclusion Criteria:

• Not covered by the social security system

• Person unable to receive informed information

• Persons deprived of liberty

• Persons under legal protection (guardianship / curatorship)

• Psychotic and/or dementia disorders

• Pregnant and breastfeeding women

Related Conditions & MeSH terms

• Stress

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Lille

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	STAI questionnaire dimension STAI completed at discharge.	STAI-ETAT	At discharge, an average 10 days
Secondary	The STAI ETAT (the current emotional state) questionnaire	State Trait Anxiety Inventory Etat - Trait (40 questions - each item has a score from 1 to 4 (4 being the highest level of anxiety))	at baseline and at discharge, an average 10 days
Secondary	The STAI-TRAIT (the usual emotional state ) questionnaire	State-Trait Anxiety Inventory (STAI-TRAIT) SCORE: 20 items in the form of a 4-response Likert scale (from 1 : low anxiety to 4 : highest anxiety). The score goes from 20 to 80 depending of the degree of anxiety	at baseline and at discharge, an average 10 days
Secondary	patient opinion questionnaire		At discharge, an average 10 days
Secondary	The difference in STAI STATUS score between the questionnaire completed post-hypnotic treatment and the questionnaire at admission		At discharge, an average 10 days
Secondary	The ordinal severity scale correlated with the STAI ETAT questionnaire score;		At discharge, an average 10 days
Secondary	Self-rated stress scale correlated with the STAI ETAT questionnaire score.		At discharge, an average 10 days